Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry.
Kojanova M, Hugo J, Velackova B, Cetkovska P, Fialova J, Dolezal T, Tichy M, Gkalpakiotis S; BIOREP study group. Kojanova M, et al. Among authors: velackova b. J Dermatolog Treat. 2022 Sep;33(6):2827-2837. doi: 10.1080/09546634.2022.2082354. Epub 2022 May 29. J Dermatolog Treat. 2022. PMID: 35635185
Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic.
Gkalpakiotis S, Cetkovska P, Arenberger P, Dolezal T, Arenbergerova M, Velackova B, Fialova J, Kojanova M; BIOREP study group. Gkalpakiotis S, et al. Among authors: velackova b. Dermatol Ther (Heidelb). 2021 Aug;11(4):1345-1355. doi: 10.1007/s13555-021-00556-2. Epub 2021 Jun 5. Dermatol Ther (Heidelb). 2021. PMID: 34089479 Free PMC article.
Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes.
Kubeš J, Haas A, Vondráček V, Andrlík M, Navrátil M, Sláviková S, Vítek P, Dědečková K, Prausová J, Ondrová B, Vinakurau Š, Grebenyuk A, Doležal T, Velacková B, Rosina J. Kubeš J, et al. Among authors: velackova b. Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):1090-1097. doi: 10.1016/j.ijrobp.2021.02.014. Epub 2021 Feb 12. Int J Radiat Oncol Biol Phys. 2021. PMID: 33587990
Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study.
Decker B, Tuzil J, Lukas M, Cerna K, Bortlik M, Velackova B, Pilnackova B, Dolezal T. Decker B, et al. Among authors: velackova b. Expert Rev Gastroenterol Hepatol. 2023 Jan;17(1):99-108. doi: 10.1080/17474124.2023.2161047. Epub 2022 Dec 22. Expert Rev Gastroenterol Hepatol. 2023. PMID: 36537197